Amphetamine

Overview

Amphetamine is a central nervous system stimulant that acts through its sympathomimetic properties, as described in the document. It primarily increases the release of dopamine and norepinephrine, while exerting a minor effect on serotonin. These neurotransmitter changes enhance alertness, concentration, energy levels, and wakefulness. Amphetamines include compounds such as methamphetamine and phentermine, and they are used clinically under strict medical supervision for specific conditions.

According to the document, amphetamine activity begins within 30–60 minutes after oral administration and occurs much faster with intravenous exposure. The drug is metabolized in the liver via the CYP2D6 pathway and is primarily excreted through the urine. While amphetamines have therapeutic roles, their stimulant effects also carry a high potential for misuse and abuse. Excessive or uncontrolled exposure can result in serious neurological, cardiovascular, and psychological consequences. Because of these risks, amphetamine testing is commonly used in medical monitoring, workplace screening, and legal settings.

Symptoms

Symptoms related to amphetamine use arise from its stimulant effects on the central nervous system and cardiovascular system. As outlined in the document, the intensity of symptoms depends on dosage, frequency of use, and individual sensitivity.

Common stimulant-related symptoms include:

1. Increased alertness and energy
2. Heightened concentration
3. Reduced appetite
4. Elevated mood or agitation

With excessive use or overdose, symptoms may progress to:

1. Hyperactivity
2. High blood pressure
3. Rapid heartbeat
4. Heavy sweating
5. Dilated pupils
6. Hyperthermia
7. Aggressiveness
8. Irrational or violent behavior
9. Severe agitation
10. Psychosis

The document also highlights that chronic exposure may lead to neurotoxicity, cognitive deficits, addiction, and physical dependence, reflecting the serious long-term impact of amphetamine misuse.

Causes

The effects and complications associated with amphetamine result from its mechanism of action on neurotransmitters. As described in the document, amphetamine increases the release of dopamine and norepinephrine while inhibiting their reuptake. This leads to prolonged stimulation of neural pathways responsible for alertness, motivation, and reward.

Causes of amphetamine-related symptoms and toxicity include:

1. Excessive stimulation of the central nervous system
2. Elevated catecholamine levels
3. Repeated or high-dose exposure
4. Rapid absorption through non-medical routes
5. Impaired metabolism or excretion

These mechanisms explain the drug’s ability to produce euphoria, agitation, hallucinations, and, in severe cases, convulsions, stroke, and heart disease.

Risk Factors

Risk factors associated with amphetamine exposure and adverse effects are clearly described in the document and relate to both medical and non-medical use.

Key risk factors include:

1. Use of amphetamines without medical supervision
2. High or repeated dosing
3. History of substance use disorder
4. Underlying cardiovascular disease
5. Pre-existing neurological or psychiatric conditions
6. Use in environments promoting prolonged wakefulness or physical exertion
7. Adolescents and young adults are exposed through recreational use
8. Individuals undergoing workplace or legal drug screening

The document also notes that chronic use significantly increases the risk of addiction, dependence, and long-term neurological damage.

Prevention

Prevention of amphetamine-related harm focuses on controlled use, monitoring, and early detection, as outlined in the document.

Preventive measures include:

1. Strict medical supervision when amphetamines are prescribed
2. Adherence to recommended doses for approved indications
3. Regular monitoring for signs of misuse or overdose
4. Avoiding recreational or non-prescribed use
5. Screening individuals in workplaces, clinical settings, and legal systems using amphetamine testing

For laboratory testing and monitoring, the document emphasizes:

1. No special patient preparation required before testing
2. Proper sample collection using 3.0 ml of blood in a plain red-capped tube
3. Early separation of serum and timely laboratory processing
4. Use of urine samples for routine screening
5. Awareness that testing is time-sensitive and results depend on correct timing and sample integrity

Early identification of amphetamine exposure and careful interpretation of test results help prevent severe complications such as psychosis, cardiovascular events, and long-term neurological damage.